We are live on
!
Find out more
Mackenzie Financial Portfolio holdings
AUM
$83.3B
1-Year Est. Return
31.19%
This Fund
S&P 500
This Quarter
Est. Return
+0.48%
1 Year Est. Return
+31.19%
3 Year Est. Return
+75.49%
5 Year Est. Return
+99.03%
10 Year Est. Return
+295.58%
AUM
$67.3B
AUM Growth
-$2.09B
(-3%)
Cap. Flow
-$1.53B
Cap. Flow
% of AUM
-2.28%
Top 10 Holdings %
Top 10 Hldgs %
22.59%
Holding
1,667
New
146
Increased
574
Reduced
656
Closed
131
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$187M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$173M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$164M |
| 4 |
Apple
AAPL
|
+$142M |
| 5 |
Shopify
SHOP
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$241M |
| 2 |
Aon
AON
|
+$160M |
| 3 |
Bank of Montreal
BMO
|
+$157M |
| 4 |
Telus
TU
|
+$129M |
| 5 |
Copart
CPRT
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Financials | 20.78% |
| 3 | Industrials | 12.2% |
| 4 | Healthcare | 9.16% |
| 5 | Energy | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
E.W. Scripps
SSP
$270M
| $63.5K | ﹤0.01% |
+20,238
| New | +$64.1K |
|
|
DHC
1477
Diversified Healthcare Trust
DHC
$2.15B
| $63.2K | ﹤0.01% |
20,726
-7,970
| -28% | -$20.2K |
|
1478
Vanda Pharmaceuticals
VNDA
$304M
| $61.8K | ﹤0.01% |
10,937
-4,027
| -27% | -$20.8K |
|
1479
Compass
COMP
$8.67B
| $60.9K | ﹤0.01% |
16,915
| – | – |
|
|
EGRX
1480
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $60.4K | ﹤0.01% |
+10,786
| New | +$47K |
|
|
ETWO
1481
DELISTED
E2open Parent Holdings
ETWO
| $58.5K | ﹤0.01% |
13,022
| – | – |
|
1482
Information Services Group
III
$204M
| $58.1K | ﹤0.01% |
19,760
| – | – |
|
1483
Pitney Bowes
PBI
$2.39B
| $57.6K | ﹤0.01% |
11,341
| – | – |
|
|
EEX
1484
DELISTED
Emerald Holding
EEX
| $57K | ﹤0.01% |
10,026
-5,746
| -36% | -$34.5K |
|
|
PGRE
1485
DELISTED
Paramount Group
PGRE
| $56.7K | ﹤0.01% |
12,251
| – | – |
|
|
TRUE
1486
DELISTED
TrueCar
TRUE
| $56.6K | ﹤0.01% |
18,076
-25,325
| -58% | -$74.2K |
|
|
SVC
1487
Service Properties Trust
SVC
$1.05B
| $54.5K | ﹤0.01% |
2,122
-127
| -6% | -$3.65K |
|
1488
Nektar Therapeutics
NKTR
$2.39B
| $54.3K | ﹤0.01% |
2,918
-3,551
| -55% | -$74.8K |
|
1489
Sabre
SABR
$716M
| $53.4K | ﹤0.01% |
20,001
| – | – |
|
|
PSTX
1490
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $51.4K | ﹤0.01% |
+17,616
| New | +$48.2K |
|
|
BDN
1491
Brandywine Realty Trust
BDN
$509M
| $49.8K | ﹤0.01% |
11,106
| – | – |
|
1492
Aldeyra Therapeutics
ALDX
$97.1M
| $49.7K | ﹤0.01% |
15,024
-493
| -3% | -$1.93K |
|
1493
Globalstar
GSAT
$10.1B
| $49.6K | ﹤0.01% |
2,951
| – | – |
|
1494
Lantronix
LTRX
$223M
| $49.6K | ﹤0.01% |
+13,965
| New | +$50.1K |
|
1495
iHeartMedia
IHRT
$531M
| $49.6K | ﹤0.01% |
45,475
| – | – |
|
1496
Aurora
AUR
$11.7B
| $49.4K | ﹤0.01% |
17,849
-1,247
| -7% | -$3.45K |
|
1497
Nordic American Tanker
NAT
$1.36B
| $49.3K | ﹤0.01% |
12,394
| – | – |
|
1498
Leslie's
LESL
$8.33M
| $47.1K | ﹤0.01% |
563
| – | – |
|
|
KYNB
1499
Kyntra Bio
KYNB
$27.4M
| $43.6K | ﹤0.01% |
1,953
+941
| +93% | +$29.1K |
|
1500
Spero Therapeutics
SPRO
$68.9M
| $42.5K | ﹤0.01% |
32,729
+4,287
| +15% | +$6.47K |
|
Similar funds
Mackenzie Financial's Q2 2024 Portfolio in Review
As of Q2 2024, Mackenzie Financial held 1,667 positions worth $67.3B, down 3% from $69.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Mackenzie Financial's Q2 2024 filing shows 146 new, 574 increased, 656 reduced and 131 closed positions. Its largest new stake was DoubleVerify: 2,722,926 shares worth $53M. The largest sale was SPDR Gold Trust, an estimated $241M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.
- Mackenzie Financial's largest Q2 2024 buy was DoubleVerify: 2,722,926 shares worth $53M.
- Mackenzie Financial added most to ExxonMobil in Q2 2024, an estimated $187M increase.
- Mackenzie Financial's biggest Q2 2024 reduction was SPDR Gold Trust, cutting an estimated $241M.
- Mackenzie Financial fully exited iShares US Medical Devices ETF in Q2 2024, selling an estimated $15.7M.
- Mackenzie Financial's ten largest holdings make up 23% of its $67.3B portfolio in Q2 2024.
- Mackenzie Financial opened 146 new positions and closed 131 in Q2 2024.
- Mackenzie Financial's portfolio value fell 3% quarter-over-quarter to $67.3B.
Based on Mackenzie Financial's 13F filing for Q2 2024, filed 14 Aug 2024.